• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MYB 介导的顺铂耐药性的调控涉及卵巢癌细胞中的 miR-21-wnt 信号轴。

Regulation of MYB mediated cisplatin resistance of ovarian cancer cells involves miR-21-wnt signaling axis.

机构信息

School of Nursing, Jilin University, Changchun, Jilin, 130021, China.

Department of Radiotherapy, Second Hospital of Jilin University, Changchun, 130022, Jilin, China.

出版信息

Sci Rep. 2020 Apr 23;10(1):6893. doi: 10.1038/s41598-020-63396-8.

DOI:10.1038/s41598-020-63396-8
PMID:32327705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7181810/
Abstract

c-MYB has been reported to be elevated in few cancers, including in ovarian cancer. It influences resistance to cisplatin but the details are not very well understood. The objective of this study was to further evaluate role of c-MYB in ovarian cancer's cisplatin resistance. To elucidate the underlying mechanism of cisplatin resistance in ovarian cancer, we focused on the epigenetic regulation by miRNAs. Two cell lines, ES2 and OVCAR3, were used as the model systems. C-MYB expression was either up-regulated or silenced and the resulting effect on cisplatin resistance evaluated, along with the mechanistic role of miR-21, through transfections with pre/anti-miRNAs. An in vivo cisplatin resistance model was also employed to verify findings. High c-MYB correlated with increased miR-21. High c-MYB also resulted in induction of EMT and increased resistance against cisplatin which was attenuated by anti-miR-200s. c-MYB decreased β-catenin phosphorylation and thus activated wnt signaling. Silencing of c-MYB resulted in reduced miR-21 levels, reduced EMT, reduced cisplatin IC-50s and increased β-catenin phosphorylation. In an in vivo mice model of cisplatin resistance, c-MYB overexpressing ES2 xenografts were more aggressive than their control counterparts. These c-MYB overexpressing ES xenografts were significantly more resistant to cisplatin but could be sensitized to cisplatin by anti-miR-21. Our results provide a novel mechanism of cisplatin resistance by c-MYB which involves an essential role of miR-21.

摘要

c-MYB 在少数癌症中被报道升高,包括卵巢癌。它影响顺铂耐药,但细节尚不清楚。本研究的目的是进一步评估 c-MYB 在卵巢癌顺铂耐药中的作用。为了阐明卵巢癌顺铂耐药的潜在机制,我们专注于 miRNA 的表观遗传调控。使用 ES2 和 OVCAR3 两个细胞系作为模型系统。c-MYB 的表达被上调或沉默,并评估其对顺铂耐药性的影响,同时通过 pre/anti-miRNAs 的转染研究 miR-21 的机制作用。还采用体内顺铂耐药模型来验证研究结果。高 c-MYB 与 miR-21 增加相关。高 c-MYB 还导致 EMT 的诱导和对顺铂的耐药性增加,这可以通过抗 miR-200 减弱。c-MYB 降低β-连环蛋白磷酸化,从而激活 wnt 信号。沉默 c-MYB 导致 miR-21 水平降低、EMT 减少、顺铂 IC50 降低和β-连环蛋白磷酸化增加。在体内顺铂耐药的小鼠模型中,c-MYB 过表达的 ES2 异种移植瘤比对照更具侵袭性。这些 c-MYB 过表达的 ES 异种移植瘤对顺铂的耐药性明显增加,但可以通过抗 miR-21 使顺铂敏感。我们的研究结果提供了 c-MYB 引起顺铂耐药的新机制,该机制涉及 miR-21 的重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e2/7181810/6b0197e245be/41598_2020_63396_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e2/7181810/3f50b9fe1db4/41598_2020_63396_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e2/7181810/164a24ce6874/41598_2020_63396_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e2/7181810/73bbaf6cd6ee/41598_2020_63396_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e2/7181810/40f6479a5291/41598_2020_63396_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e2/7181810/6b0197e245be/41598_2020_63396_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e2/7181810/3f50b9fe1db4/41598_2020_63396_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e2/7181810/164a24ce6874/41598_2020_63396_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e2/7181810/73bbaf6cd6ee/41598_2020_63396_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e2/7181810/40f6479a5291/41598_2020_63396_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e2/7181810/6b0197e245be/41598_2020_63396_Fig5_HTML.jpg

相似文献

1
Regulation of MYB mediated cisplatin resistance of ovarian cancer cells involves miR-21-wnt signaling axis.MYB 介导的顺铂耐药性的调控涉及卵巢癌细胞中的 miR-21-wnt 信号轴。
Sci Rep. 2020 Apr 23;10(1):6893. doi: 10.1038/s41598-020-63396-8.
2
Proto-oncogene c-Myb potentiates cisplatin resistance of ovarian cancer cells by downregulating lncRNA NKILA and modulating cancer stemness and LIN28A-let7 axis.原癌基因 c-Myb 通过下调 lncRNA NKILA 以及调节癌症干性和 LIN28A-let7 轴来增强卵巢癌细胞对顺铂的耐药性。
J Ovarian Res. 2024 May 14;17(1):102. doi: 10.1186/s13048-024-01429-w.
3
MicroRNA-302 represses epithelial-mesenchymal transition and cisplatin resistance by regulating ATAD2 in ovarian carcinoma.MicroRNA-302 通过调控卵巢癌细胞中的 ATAD2 抑制上皮-间质转化和顺铂耐药性。
Exp Cell Res. 2020 Nov 1;396(1):112241. doi: 10.1016/j.yexcr.2020.112241. Epub 2020 Aug 21.
4
Overexpression of microRNA-195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3β/β-catenin signaling pathway.miR-195-5p 的过表达通过抑制 PSAT1 依赖性 GSK3β/β-catenin 信号通路降低卵巢癌细胞顺铂耐药性和血管生成。
J Transl Med. 2019 Jun 6;17(1):190. doi: 10.1186/s12967-019-1932-1.
5
Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.敲低长链非编码 RNA HOTAIR 通过上调 miR-34a 抑制 PI3K/Akt 和 Wnt/β-catenin 信号通路抑制胃癌细胞顺铂耐药。
Int J Biol Macromol. 2018 Feb;107(Pt B):2620-2629. doi: 10.1016/j.ijbiomac.2017.10.154. Epub 2017 Oct 26.
6
Novel role of lncRNA CHRF in cisplatin resistance of ovarian cancer is mediated by miR-10b induced EMT and STAT3 signaling.长链非编码 RNA CHRF 在顺铂耐药卵巢癌中的新作用是通过 miR-10b 诱导的 EMT 和 STAT3 信号传导介导的。
Sci Rep. 2020 Sep 8;10(1):14768. doi: 10.1038/s41598-020-71153-0.
7
miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.微小RNA-206通过靶向间质表皮转化因子(MET)部分调节人肺腺癌细胞中的顺铂耐药性和上皮-间质转化。
Oncotarget. 2016 Apr 26;7(17):24510-26. doi: 10.18632/oncotarget.8229.
8
Modulation of Myb-induced NF-kB -STAT3 signaling and resulting cisplatin resistance in ovarian cancer by dietary factors.膳食因子对 Myb 诱导的 NF-κB-STAT3 信号转导的调节及其对卵巢癌顺铂耐药性的影响。
J Cell Physiol. 2019 Nov;234(11):21126-21134. doi: 10.1002/jcp.28715. Epub 2019 Apr 29.
9
MiR-1294 confers cisplatin resistance in ovarian Cancer cells by targeting IGF1R.miR-1294 通过靶向 IGF1R 赋予卵巢癌细胞顺铂耐药性。
Biomed Pharmacother. 2018 Oct;106:1357-1363. doi: 10.1016/j.biopha.2018.07.059. Epub 2018 Jul 23.
10
miR-200 affects tamoxifen resistance in breast cancer cells through regulation of MYB.miR-200 通过调控 MYB 影响乳腺癌细胞对他莫昔芬的耐药性。
Sci Rep. 2019 Dec 11;9(1):18844. doi: 10.1038/s41598-019-54289-6.

引用本文的文献

1
MicroRNA‑mediated approaches in ovarian cancer therapy: A comprehensive systematic review.微小RNA介导的卵巢癌治疗方法:一项全面的系统综述。
Oncol Lett. 2024 Aug 12;28(4):491. doi: 10.3892/ol.2024.14624. eCollection 2024 Oct.
2
Identification of New Chemoresistance-Associated Genes in Triple-Negative Breast Cancer by Single-Cell Transcriptomic Analysis.单细胞转录组分析鉴定三阴性乳腺癌中的新化疗耐药相关基因。
Int J Mol Sci. 2024 Jun 22;25(13):6853. doi: 10.3390/ijms25136853.
3
Emerging role of MYB transcription factors in cancer drug resistance.

本文引用的文献

1
MicroRNA-27a (miR-27a) in Solid Tumors: A Review Based on Mechanisms and Clinical Observations.实体瘤中的微小RNA-27a(miR-27a):基于机制与临床观察的综述
Front Oncol. 2019 Sep 12;9:893. doi: 10.3389/fonc.2019.00893. eCollection 2019.
2
Modulation of Myb-induced NF-kB -STAT3 signaling and resulting cisplatin resistance in ovarian cancer by dietary factors.膳食因子对 Myb 诱导的 NF-κB-STAT3 信号转导的调节及其对卵巢癌顺铂耐药性的影响。
J Cell Physiol. 2019 Nov;234(11):21126-21134. doi: 10.1002/jcp.28715. Epub 2019 Apr 29.
3
Cisplatin: The first metal based anticancer drug.
MYB转录因子在癌症耐药性中的新作用。
Cancer Drug Resist. 2024 Apr 30;7:15. doi: 10.20517/cdr.2023.158. eCollection 2024.
4
Proto-oncogene c-Myb potentiates cisplatin resistance of ovarian cancer cells by downregulating lncRNA NKILA and modulating cancer stemness and LIN28A-let7 axis.原癌基因 c-Myb 通过下调 lncRNA NKILA 以及调节癌症干性和 LIN28A-let7 轴来增强卵巢癌细胞对顺铂的耐药性。
J Ovarian Res. 2024 May 14;17(1):102. doi: 10.1186/s13048-024-01429-w.
5
Overcoming therapeutic resistance to platinum-based drugs by targeting Epithelial-Mesenchymal transition.通过靶向上皮-间质转化克服对铂类药物的治疗耐药性。
Front Oncol. 2022 Oct 14;12:1008027. doi: 10.3389/fonc.2022.1008027. eCollection 2022.
6
Guest Edited Collection: Epigenetics within the tumor microenvironment.客座编辑专刊:肿瘤微环境中的表观遗传学。
Sci Rep. 2022 Sep 5;12(1):15089. doi: 10.1038/s41598-022-19042-6.
7
Revisiting the miR-200 Family: A Clan of Five Siblings with Essential Roles in Development and Disease.重新审视 miR-200 家族:五兄妹在发育和疾病中的关键作用。
Biomolecules. 2022 Jun 3;12(6):781. doi: 10.3390/biom12060781.
8
Transcription factor c-Myb: novel prognostic factor in osteosarcoma.转录因子 c-Myb:骨肉瘤的新型预后因素。
Clin Exp Metastasis. 2022 Apr;39(2):375-390. doi: 10.1007/s10585-021-10145-4. Epub 2022 Jan 7.
9
Intricate crosstalk between MYB and noncoding RNAs in cancer.MYB与非编码RNA在癌症中的复杂相互作用。
Cancer Cell Int. 2021 Dec 7;21(1):653. doi: 10.1186/s12935-021-02362-4.
10
MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells.MicroRNAs 作为卵巢癌细胞顺铂耐药的关键调节因子。
J Ovarian Res. 2021 Sep 30;14(1):127. doi: 10.1186/s13048-021-00882-1.
顺铂:第一种金属类抗癌药物。
Bioorg Chem. 2019 Jul;88:102925. doi: 10.1016/j.bioorg.2019.102925. Epub 2019 Apr 11.
4
MicroRNA-137 reduces stemness features of pancreatic cancer cells by targeting KLF12.microRNA-137 通过靶向 KLF12 减少胰腺癌细胞的干性特征。
J Exp Clin Cancer Res. 2019 Mar 12;38(1):126. doi: 10.1186/s13046-019-1105-3.
5
miR-200b and miR-200c co-contribute to the cisplatin sensitivity of ovarian cancer cells by targeting DNA methyltransferases.miR-200b和miR-200c通过靶向DNA甲基转移酶共同促进卵巢癌细胞对顺铂的敏感性。
Oncol Lett. 2019 Feb;17(2):1453-1460. doi: 10.3892/ol.2018.9745. Epub 2018 Nov 22.
6
Comprehensive review on how platinum- and taxane-based chemotherapy of ovarian cancer affects biology of normal cells.铂类和紫杉烷类化疗药物治疗卵巢癌对正常细胞生物学的影响的综合综述。
Cell Mol Life Sci. 2019 Feb;76(4):681-697. doi: 10.1007/s00018-018-2954-1. Epub 2018 Oct 31.
7
Non-coding RNA/microRNA-modulatory dietary factors and natural products for improved cancer therapy and prevention: Alkaloids, organosulfur compounds, aliphatic carboxylic acids and water-soluble vitamins.用于改善癌症治疗与预防的非编码RNA/微小RNA调节性饮食因子及天然产物:生物碱、有机硫化合物、脂肪族羧酸和水溶性维生素。
Noncoding RNA Res. 2016 Sep 3;1(1):51-63. doi: 10.1016/j.ncrna.2016.09.001. eCollection 2016 Oct.
8
Role of cancer stem cells and microRNA in resistance to chemotherapy in patients with ovarian cancer.癌症干细胞和微小RNA在卵巢癌患者化疗耐药中的作用
Eur J Gynaecol Oncol. 2017;38(2):181-183.
9
MicroRNA-130b targets PTEN to induce resistance to cisplatin in lung cancer cells by activating Wnt/β-catenin pathway.微小 RNA-130b 通过激活 Wnt/β-连环蛋白通路靶向 PTEN 诱导肺癌细胞对顺铂耐药。
Cell Biochem Funct. 2018 Jun;36(4):194-202. doi: 10.1002/cbf.3331. Epub 2018 Apr 13.
10
Biomarkers of platinum resistance in ovarian cancer: what can we use to improve treatment.卵巢癌铂耐药的生物标志物:我们可以用什么来改善治疗。
Endocr Relat Cancer. 2018 May;25(5):R303-R318. doi: 10.1530/ERC-17-0336. Epub 2018 Feb 27.